Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.915 USD | +8.81% | -5.30% | -87.26% |
Apr. 11 | Baird Trims Amylyx Pharmaceuticals' Price Target to $3 From $4, Maintains Neutral Rating | MT |
Apr. 10 | Transcript : Amylyx Pharmaceuticals, Inc. - Special Call |
- Stock Market
- Equities
- AMLX Stock
- News Amylyx Pharmaceuticals, Inc.
- MarketScreener Editorial Features